Extended mortality benefit of early postinfarction reperfusion.
Rawles
J
J
D016255:Anistreplase / Q000627:therapeutic use; D004311:Double-Blind Method; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality*; D015425:Myocardial Reperfusion / Q000401:mortality*; D016032:Randomized Controlled Trials as Topic; D013300:Streptokinase / Q000627:therapeutic use; D013318:Stroke Volume; D015912:Thrombolytic Therapy
D005343:Fibrinolytic Agents; D016255:Anistreplase; D013300:Streptokinase